- Home
- PROP vs APLT Comparison
PROP vs APLT Comparison
Compare PROP & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROP
- APLT
- Stock Information
- Founded
- PROP 2001
- APLT 2016
- Country
- PROP United States
- APLT United States
- Employees
- PROP N/A
- APLT N/A
- Industry
- PROP Investment Bankers/Brokers/Service
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PROP Finance
- APLT Health Care
- Exchange
- PROP Nasdaq
- APLT Nasdaq
- Market Cap
- PROP 190.0M
- APLT 37.5M
- IPO Year
- PROP N/A
- APLT 2019
- Fundamental
- Price
- PROP $3.66
- APLT $0.40
- Analyst Decision
- PROP
- APLT Buy
- Analyst Count
- PROP 0
- APLT 7
- Target Price
- PROP N/A
- APLT $6.10
- AVG Volume (30 Days)
- PROP 534.4K
- APLT 2.5M
- Earning Date
- PROP 01-01-0001
- APLT 04-14-2025
- Dividend Yield
- PROP N/A
- APLT N/A
- EPS Growth
- PROP N/A
- APLT N/A
- EPS
- PROP N/A
- APLT N/A
- Revenue
- PROP $7,939,000.00
- APLT $455,000.00
- Revenue This Year
- PROP $8,955.68
- APLT $1,768.13
- Revenue Next Year
- PROP N/A
- APLT $361.28
- P/E Ratio
- PROP N/A
- APLT N/A
- Revenue Growth
- PROP N/A
- APLT N/A
- 52 Week Low
- PROP $3.35
- APLT $0.30
- 52 Week High
- PROP $15.68
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PROP 32.98
- APLT 47.17
- Support Level
- PROP $3.92
- APLT $0.31
- Resistance Level
- PROP $4.15
- APLT $0.43
- Average True Range (ATR)
- PROP 0.44
- APLT 0.05
- MACD
- PROP 0.03
- APLT 0.01
- Stochastic Oscillator
- PROP 21.72
- APLT 77.39
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.